98 related articles for article (PubMed ID: 11285777)
1. [Role of radiotherapy in induction of myeloid secondary neoplasms after high dosage therapy of malignant lymphomas].
Belka C
Strahlenther Onkol; 2001 Mar; 177(3):165-6. PubMed ID: 11285777
[No Abstract] [Full Text] [Related]
2. Role of radiation dose in the risk of secondary leukemia after a solid tumor in childhood treated between 1980 and 1999.
Allard A; Haddy N; Le Deley MC; Rubino C; Lassalle M; Samsaldin A; Quiniou E; Chompret A; Lefkopoulos D; Diallo I; de Vathaire F
Int J Radiat Oncol Biol Phys; 2010 Dec; 78(5):1474-82. PubMed ID: 20303670
[TBL] [Abstract][Full Text] [Related]
3. Long-term survival following radiotherapy and cytarabine chemotherapy for sporadic primary central nervous system lymphoma.
Pöttgen C; Stuschke M; Stüben G; Schmitz A; Schwechheimer K; Wacker HH; Rauhut F; Kleuker S; Wilhelm H; Grehl S; Fehlings T
Strahlenther Onkol; 2003 Sep; 179(9):626-32. PubMed ID: 14628129
[TBL] [Abstract][Full Text] [Related]
4. Primary CNS lymphoma treated with combined intra-arterial ACNU and radiotherapy.
Sonoda Y; Matsumoto K; Kakuto Y; Nishino Y; Kumabe T; Tominaga T; Katakura R
Acta Neurochir (Wien); 2007 Nov; 149(11):1183-9; discussion 1189. PubMed ID: 17712511
[TBL] [Abstract][Full Text] [Related]
5. Pilot study of modified version of CHOP plus radiotherapy for early-stage aggressive non-Hodgkin's lymphoma of the head and neck.
Nishioka T; Tsuchiya K; Nishioka S; Kitahara T; Ohmori K; Homma A; Aoyma H; Shindoh M; Shirato H
Int J Radiat Oncol Biol Phys; 2004 Nov; 60(3):847-52. PubMed ID: 15465202
[TBL] [Abstract][Full Text] [Related]
6. Estimation of cancer risks from radiotherapy of benign diseases.
Trott KR; Kamprad F
Strahlenther Onkol; 2006 Aug; 182(8):431-6. PubMed ID: 16896588
[TBL] [Abstract][Full Text] [Related]
7. [Significance of typing in the survival of malignant lymphomas].
Su ZL
Zhonghua Zhong Liu Za Zhi; 1992 May; 14(3):186-9. PubMed ID: 1396057
[TBL] [Abstract][Full Text] [Related]
8. Outcome of patients who develop acute leukemia or myelodysplasia as a second malignancy after solid tumors treated surgically or with strategies that include chemotherapy and/or radiation.
Abdelhameed A; Pond GR; Mitsakakis N; Brandwein J; Chun K; Gupta V; Kamel-Reid S; Lipton JH; Minden MD; Schimmer A; Schuh A; Yee K; Messner HA
Cancer; 2008 Apr; 112(7):1513-21. PubMed ID: 18286528
[TBL] [Abstract][Full Text] [Related]
9. Low-dose radiation and leukemia.
Linos A; Gray JE; Orvis AL; Kyle RA; O'Fallon WM; Kurland LT
N Engl J Med; 1980 May; 302(20):1101-5. PubMed ID: 6929033
[TBL] [Abstract][Full Text] [Related]
10. Radiation-induced leukemia at doses relevant to radiation therapy: modeling mechanisms and estimating risks.
Shuryak I; Sachs RK; Hlatky L; Little MP; Hahnfeldt P; Brenner DJ
J Natl Cancer Inst; 2006 Dec; 98(24):1794-806. PubMed ID: 17179481
[TBL] [Abstract][Full Text] [Related]
11. Clinicopathological analysis of 598 malignant lymphomas in Taiwan: seven-year experience in a single institution.
Lee MY; Tan TD; Feng AC; Liu MC
Am J Hematol; 2006 Aug; 81(8):568-75. PubMed ID: 16823825
[TBL] [Abstract][Full Text] [Related]
12. Phase II study of concomitant chemoradiotherapy in bulky refractory or chemoresistant relapsed lymphomas.
Girinsky T; Lapusan S; Ribrag V; Koscielny S; Ferme C; Carde P
Int J Radiat Oncol Biol Phys; 2005 Feb; 61(2):476-9. PubMed ID: 15667970
[TBL] [Abstract][Full Text] [Related]
13. Uncertainties in contemporary treatment of aggressive lymphomas.
Cox JD; Ha CS; Lee HK; Dabaja BS; Wilder RB
Rays; 2003; 28(3):289-92. PubMed ID: 15018315
[TBL] [Abstract][Full Text] [Related]
14. Risk factors before autologous stem-cell transplantation for lymphoma predict for secondary myelodysplasia and acute myelogenous leukemia.
Kalaycio M; Rybicki L; Pohlman B; Sobecks R; Andresen S; Kuczkowski E; Bolwell B
J Clin Oncol; 2006 Aug; 24(22):3604-10. PubMed ID: 16877727
[TBL] [Abstract][Full Text] [Related]
15. Secondary myeloid leukemia and myelodysplastic syndromes in patients treated for Hodgkin's disease: a report from the German Hodgkin's Lymphoma Study Group.
Josting A; Wiedenmann S; Franklin J; May M; Sieber M; Wolf J; Engert A; Diehl V;
J Clin Oncol; 2003 Sep; 21(18):3440-6. PubMed ID: 12668650
[TBL] [Abstract][Full Text] [Related]
16. [Primary non-Hodgkin's lymphoma of the paranasal sinuses: a report of 14 cases].
Su ZY; Zhang DS; Zhu MQ; Shi YX; Jiang WQ
Ai Zheng; 2007 Aug; 26(8):919-22. PubMed ID: 17697560
[TBL] [Abstract][Full Text] [Related]
17. Orbital marginal zone B-cell lymphoma of MALT: radiotherapy results and clinical behavior.
Suh CO; Shim SJ; Lee SW; Yang WI; Lee SY; Hahn JS
Int J Radiat Oncol Biol Phys; 2006 May; 65(1):228-33. PubMed ID: 16503386
[TBL] [Abstract][Full Text] [Related]
18. [Survival outcomes of T-cell non-Hodgkin's lymphoma: a report of 111 cases].
Huang Y; Lin TY; Wu QL; Su ZL; Huang HQ; Xia ZJ; Sun XF; Jiang WQ; Guan ZZ
Ai Zheng; 2005 Apr; 24(4):470-4. PubMed ID: 15820072
[TBL] [Abstract][Full Text] [Related]
19. Secondary malignancies after treatment for indolent non-Hodgkin's lymphoma: a 16-year follow-up study.
Sacchi S; Marcheselli L; Bari A; Marcheselli R; Pozzi S; Luminari S; Lombardo M; Buda G; Lazzaro A; Gobbi PG; Stelitano C; Morabito F; Quarta G; Brugiatelli M
Haematologica; 2008 Mar; 93(3):398-404. PubMed ID: 18268277
[TBL] [Abstract][Full Text] [Related]
20. Low-dose palliative radiotherapy for cutaneous B- and T-cell lymphomas.
Neelis KJ; Schimmel EC; Vermeer MH; Senff NJ; Willemze R; Noordijk EM
Int J Radiat Oncol Biol Phys; 2009 May; 74(1):154-8. PubMed ID: 18834672
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
